A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter E. Zage, M.D.
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Rady Children'S Hospital of San Diego
San Diego, California, United States
- Georgetown Medical Center
Washington D.C., District of Columbia, United States
- All Children'S Hospital in Florida
St. Petersburg, Florida, United States
- Lsu Health Sciences Center; Children'S Hospital
New Orleans, Louisiana, United States
- Children'S Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States
- Children'S Hospital at Montefiore
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Nationwide Childrens Hospital
Columbus, Ohio, United States
- University of Oklahoma Cancer Center
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Us Oncology
Dallas, Texas, United States
- the University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
- University of Utah Medical Center
Salt Lake City, Utah, United States
- Vermont Cancer Center
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 31 Aug 2010
- Completion
- —
- Last update posted
- 8 Mar 2013
- Registered enrollment
- 1
- Registry id
- NCT00969722
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.